Another good example is the cystic fibrosis drugs like Kalydeco. Game changing therapy that corrects the gene defect and restores near normal lung function.

Available shortly after launch in the US in 2012. Even Medicaid patients (insurance for poor Americans) had access.

The UK didn’t pay for it until 2020. Eight years later.

And in Canada only 6 of 12 provinces/territories pay for it and only for children. If you’re an adult, well, you’re out of luck.